Recombination Therapeutics
PrivateCompany Overview
Recombination Therapeutics operates in Healthcare & Life Sciences and is based in Philadelphia, Pennsylvania.
Recombination Therapeutics is a precision oncology company that develops cancer therapeutics by targeting DNA damage response pathways to overcome drug resistance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Recombination Therapeutics Comparables
Compare Recombination Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SynRx Therapeutics | 87% | |
| Breakpoint Therapeutics | 85% | |
| MOMA Therapeutics | 84% |
For institutional investors. Book with your work email.
Recombination Therapeutics Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 1126% MoM to 613.
For institutional investors. Book with your work email.
Recombination Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Recombination Therapeutics's valuation, stock price, and market status.
Is Recombination Therapeutics a public or private company?
Recombination Therapeutics is a private company.
What is the current stock price of Recombination Therapeutics?
Recombination Therapeutics is a private company, so its shares have no public market price. Caplight tracks Recombination Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Recombination Therapeutics worth (valuation)?
Valuation information for Recombination Therapeutics is not publicly available.
Can I buy Recombination Therapeutics stock?
Recombination Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Recombination Therapeutics's last funding round?
Funding round information for Recombination Therapeutics is not publicly available.
Who are the main investors in Recombination Therapeutics?
Investor information for Recombination Therapeutics is not publicly disclosed.
Will Recombination Therapeutics IPO soon?
No public IPO plans have been announced for Recombination Therapeutics.
How can I track Recombination Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Recombination Therapeutics's shares on secondary markets.